Extension sponsoring workshop on controlling asthma and allergy triggers – Daily Journal Online


Daily Journal Online

Extension sponsoring workshop on controlling asthma and allergy triggers
Daily Journal Online
Children may be particularly sensitive to dust mites, the invisible creatures lurking in bedding and furniture. A free workshop hosted by the Missouri Extension in Ste. Genevieve on Dec. 14 will offer attendees information about controlling common

View full post on asthma – Google News

Asthma costs Australia almost $28b every year, report finds – ABC Online


ABC Online

Asthma costs Australia almost $28b every year, report finds
ABC Online
The reported estimated the total cost of asthma in Australia in 2015 was $27.9 billion, comprised of $3.3 billion in economic costs and $24.7 billion in "burden of disease" costs. It defines "burden of disease" costs as those that flow from suffering
Asthma costs Aust $28ba year: report9news.com.au
Australia's $28 billion asthma billThe Advertiser

all 6 news articles »

View full post on asthma – Google News

People without asthma can experience breathing difficulties during bushfires … – ABC Online


ABC Online

People without asthma can experience breathing difficulties during bushfires
ABC Online
Irritants in the air can trigger people without asthma to experience symptoms of altered breathing during bushfire season. Chair of the National Asthma Council's pharmacist group Marcus Weidinger said it was not just people with diagnosed respiratory …

and more »

View full post on asthma – Google News

Tasmanian researchers scrutinise athletes’ use of asthma treatment as … – ABC Online


ABC Online

Tasmanian researchers scrutinise athletes' use of asthma treatment as
ABC Online
The World Anti-Doping Agency (WADA) is funding research at the University of Tasmania to improve the testing regime for a common asthma drug suspected of enhancing athletic performance. Dr Glenn Jacobson from the University of Tasmania's School of …

View full post on asthma – Google News

Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

Related Articles

Beliefs about medication predict the misattribution of a common symptom as a medication side effect – Evidence from an analogue online study.

J Psychosom Res. 2015 Oct 13;

Authors: Heller MK, Chapman SC, Horne R

Abstract
OBJECTIVE: Some perceived medication side effects may be ‘normal’ symptoms that patients misattribute to the medication. Using an analogue approach, we tested if medication beliefs predict whether participants misattribute a headache as a side effect and subsequently intend to stop medication.
METHODS: We recruited 690 participants, 223 reporting a past asthma diagnosis. They received information about asthma and Molair, a fictitious asthma treatment modeled on a licensed treatment (montelukast). We varied the description of efficacy and side effects (which did not include headache). Pre-exposure to this information, participants completed the Beliefs about Medicine Questionnaire (BMQ)-General and the Perceived Sensitivity to Medicines Scale (PSM), post-exposure they completed the BMQ-Specific. Participants were asked to imagine they experienced a headache while taking Molair. Finally, they rated whether the headache was a side effect (misattribution) and if they would stop taking Molair (behavioral intention).
RESULTS: Nearly a quarter (170) of participants misattributed the headache to Molair and 69 (10%) subsequently intended to stop Molair. Both outcomes were predicted by general and specific medication beliefs. Odds of misattribution (m) and behavioral intention (i) increased with higher General Harm (ORm=1.90, ORi=2.72), General Overuse (ORm=1.74, ORi=1.56) and Molair Concern beliefs (ORm=1.52, ORi=1.78, all p<.01), but decreased with General Benefit (ORm=0.72, ORi=0.53) and Molair Necessity beliefs (ORm=0.72, ORi=0.70, all p<.05).
CONCLUSION: Symptom misattribution and subsequent intentions to stop Molair were predicted by pre-exposure beliefs about medicines in general and post-exposure beliefs about Molair. Patients with negative medication beliefs may be prone to misattribute symptoms and subsequently stop medication.

PMID: 26519128 [PubMed – as supplied by publisher]

View full post on pubmed: asthma